These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
602 related articles for article (PubMed ID: 16485339)
1. Pharma's year of trouble and strife. Frantz S Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339 [No Abstract] [Full Text] [Related]
2. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk. Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527 [No Abstract] [Full Text] [Related]
3. Institute of Medicine's new drug safety report: implications for Canada. Cassels A CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086 [No Abstract] [Full Text] [Related]
4. Keeping up with drug safety information. Meadows M FDA Consum; 2006; 40(3):38-9. PubMed ID: 16906667 [No Abstract] [Full Text] [Related]
6. Beware of new drugs, study suggests. Levenson D Rep Med Guidel Outcomes Res; 2002 May; 13(10):1-2, 5. PubMed ID: 12492085 [No Abstract] [Full Text] [Related]
7. LyphoMed sparks worries. Wagner M Mod Healthc; 1988 Jul; 18(29):5. PubMed ID: 10325202 [No Abstract] [Full Text] [Related]
8. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
9. Clinical investigation of new animal drugs by veterinary practitioners. Prater DA; Bertone JJ; Letonja T; Vaughn SD J Am Vet Med Assoc; 1996 Jan; 208(2):190-4. PubMed ID: 8567369 [No Abstract] [Full Text] [Related]
10. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency. Schultheis LW; Rappaport BA Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189 [No Abstract] [Full Text] [Related]
11. What's best for the patient? Burkle WS Am J Hosp Pharm; 1983 Apr; 40(4):558. PubMed ID: 6846359 [No Abstract] [Full Text] [Related]
12. The federal preemption debate in pharmaceutical labeling product liability actions. Gross JM; Curry JA Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866 [No Abstract] [Full Text] [Related]
13. Drug product liability and health care delivery systems. Sage WM Stanford Law Rev; 1988 Apr; 40(4):989-1026. PubMed ID: 10318110 [No Abstract] [Full Text] [Related]
14. New drugs and product approvals from 2000. Taylor SE; Gage TW Tex Dent J; 2001 Nov; 118(11):1070-81. PubMed ID: 11806330 [No Abstract] [Full Text] [Related]
15. Pediatric drug development in anesthesiology: an FDA perspective. Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624 [No Abstract] [Full Text] [Related]
16. Maine law requires drug companies to provide clinical trial data. Appell D J Natl Cancer Inst; 2005 Sep; 97(17):1246. PubMed ID: 16145043 [No Abstract] [Full Text] [Related]
17. The learned intermediary doctrine: past, present and future. Alsobrook HB Leg Med; 1994; ():269-80. PubMed ID: 7830482 [No Abstract] [Full Text] [Related]
18. A critical tipping point. Zuckerman MB US News World Rep; 2002 Apr; 132(13):72. PubMed ID: 11993366 [No Abstract] [Full Text] [Related]
19. The FDA's drug review process: ensuring drugs are safe and effective. Meadows M FDA Consum; 2002; 36(4):19-24. PubMed ID: 12184298 [No Abstract] [Full Text] [Related]
20. Patient group seeks overhaul of FDA clinical trial system in court. Hede K J Natl Cancer Inst; 2006 Sep; 98(18):1268-70. PubMed ID: 16985242 [No Abstract] [Full Text] [Related] [Next] [New Search]